Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vitae Industries is a private healthcare technology company developing pharmacy compounding automation systems for personalized medication production. Its core product, the AutoCompounder, uses 3D-printing-inspired automation to help pharmacies prepare patient-specific dosage forms such as tablets, chews, gummies, and lozenges with greater consistency and labor efficiency. The company focuses on the operational side of pharmaceutical compounding rather than developing novel therapeutics, enabling pharmacies to produce customized medicines on demand. Founded out of the Brown University ecosystem, Vitae has raised seed financing from a group of early-stage venture investors and appears to operate commercially from Providence, Rhode Island. Some third-party sources suggest the business may also be referred to as BetteRx Compounding, but the Vitae Industries brand and website remain active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitae Industries.